Document is current
Any future updates will be listed below
-
Authors
Amoia, Charlie F.
Chengula, Augustino A.
Hakizimana, Jean N.
Wambura, Philemon N.
Munir, Muhammad
Misinzo, Gerald
Weger-Lucarelli, James
-
Funding
Funding for this research was provided by:
Regional Scholarship and Innovation Fund (RSIF), through the Partnership for Skills in Applied Sciences, Engineering and Technology
CeZAP ID-IGEP graduate student mini-grant 2023
OR Tambo Africa Research Chair for Viral Epidemics
- License Information
-
More Information
Article History
Received: 11 July 2024
Accepted: 10 October 2024
First Online: 25 November 2024
Declarations
:
: For the vaccine development and in vitro testing, this study was carried out according to the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The Institutional Biosafety Committee of Virginia Tech approved the research for the ND DNA vaccine. For the vaccine experimentation on animals, ethical clearance was obtained from the Office of the Vice-Chancellor, Sokoine University of Agriculture, Tanzania and Permission to undertake animal health research in Tanzania from the United Republic of Tanzania Ministry of Livestock and Fisheries (Ref. No. DB.16/324/01/137).
: The authors declare no competing interests.
